Anti-inflammatory effects of an ethanol extract of Angelica gigas in a carrageenan-air pouch inflammation model

Experimental Animals

Volumn 58, Issue 4, 2009, Pages 431-436

  Shin, Sunhee ^a   Jeon, Jeong Hee ^a   Park, Dongsun ^a   Jang, Ja Young ^a   Joo, Seong Soo ^a   Hwang, Bang Yeon ^b   Choe, Soo Young ^b   Kim, Yun Bae ^a  

^a Research Institute of Veterinary Medicine   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Angelica gigas; Carrageenan air pouch inflammation; Inflammation

Indexed keywords

ALBUMIN; ALCOHOL; ANGELICA GIGAS EXTRACT; CARRAGEENAN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NITRIC OXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; BASOPHIL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ILEITIS; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MALE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; NOTE; PLANT ROOT; POLYMORPHONUCLEAR CELL; ANGELICA; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; EXUDATE; INFLAMMATION; METABOLISM; MOUSE STRAIN; PATHOLOGY;

ANGELICA GIGAS;

ANGELICA; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; DINOPROSTONE; DISEASE MODELS, ANIMAL; ETHANOL; EXUDATES AND TRANSUDATES; INFLAMMATION; INTERLEUKIN-6; MALE; MICE; MICE, INBRED STRAINS; NITRIC OXIDE; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73349097885     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.58.431     Document Type: Note

References (45)

1. Adams, V., Nehrhoff, B., Spate, U., Linke, A., Schulze, P.C., Baur, A., Gielen, S., Hambrecht, R., and Schuler, G. 2002. Cardiovasc. Res. 54: 95-104.
2. Ahn, K.S., Sim, W.S., Lee, I.K., Seu, Y.S., and Kim, I.H. 1997. Planta Med. 63: 360-361.
3. Bae, E.A., Han, M.J., Kim, N.J., and Kim, D.H. 1998. Biol. Pharm. Bull. 21: 990-992.
4. Bresnihan, B. 2002. J. Rheumatol. Suppl. 15: 9-12.
5. Chabaud, M. 1998. J. Immunol. 161: 409-414.
6. Cho, S., Takahashi, M., Toita, S., and Cyong, J.C. 1982. Shoyakugaku Zasshi 36: 78-81.
7. Choi, H.J. and Kim, H.S. 1970. Kor. J. Pharmacol. 1: 25-32.
8. Choi, S.-S., Han, K.-J., Lee, J.-K., Lee, H.-K., Han, E.-J., Kim, D.-H., and Suh, H.-W. 2003. Life Sci. 73: 471-485.
9. Day, R. 2002. Lancet 1359: 540-541.
10. Eigler, A., Sinha, B., Hartmann, G., and Endres, S. 1997. J. Immunol. 18: 487-492.
11. Ershler, E.B. and Keller, E.T. 2000. Annu. Rev. Med. 51: 245-270.
12. Feldmann, M. 1996. Annu. Rev. Immunol. 14: 398-399.
13. Guslandi, M. 1998. Eur. J. Clin. Investig. 28: 904-907.
14. Heinrich, P.C., Castell, J.V., and Andus, T. 1990. Biochem. J. 265: 621-636.
15. Hevel, J.M. and Marietta, M.A. 1994. Methods Enzymol. 233: 250-258.
16. Hunskaar, S. and Hole, K. 1987. Pain 30: 103-114.
17. Jiang, C., Leem, H.-J., Lim, G.-X., Guo, J., Malewicz, B., Zhao, Y., Lee, E.-O., Lee, H.-J., Lee, J.-H., Kim, M.-S., Kim, S.-H., and Lu, J. 2006. Cancer Res. 66: 453-463.
18. Jiang, J., Wu, F., Lu, J., Lu, Z., and Xu, Q. 1997. Pharmacol. Res. 36: 309-314.
19. Kang, S.Y., Lee, K.Y., Park, M.J., Kim, Y.C., Markelonis, G.J., Oh, T.H., and Kim, Y.C. 2003. Neurobiol. Learn. Mem. 79: 11-18.
20. Kang, S.Y., Lee, K.Y., Sung, S.H., and Kim, Y.C. 2005. J. Nat. Prod. 68: 56-59.
21. Kang, S.Y., Lee, K.Y., Sung, S.H., Park, M.J., and Kim, Y.C. 2001. J. Nat. Prod. 64: 683-685.
22. Kim, H.H., Bang, S.S., Choi, J.S., Han, H., and Kim, I.-H. 2005. Cancer Lett. 223: 191-201.
23. Kim, J.H., Jeong, J.H., Jeon, S.T., Kim, H., Ock, J., Suk, K., Kim, S.I., Song, K.S., and Lee, W.H. 2006. Mol. Pharmacol. 89: 1783-1790.
24. Lee, J.K., Choi, S.S., Lee, H.K., Han, K.J., Han, E.J., and Suh, H.W. 2003. Planta Med. 69: 230-234.
25. Lee, Y.Y., Lee, S., Jin, J.L., and Choi, H.S. 2003. Arch. Pharm. Res. 26: 723-726.
26. Lester, R.S., Knowles, S.R., and Shear, N.H. 1998. Dermatol. Clin. 16: 277-288.
27. Lichtenstein, D.R., Syngal, S., and Wolfe, M.M. 1995. Arthritis Rheum. 38: 5-18.
28. Marietta, M.A. 1994. Cell 78: 927-930.
29. Marietta, M.A., Yoon, P.S., Iyengar, R., Leaf, C.D., and Wishnok, J.S. 1988. Biochemistry 27: 8706-8711.
30. Moncada, S., Palmer, R.M., and Higgs, E.A. 1991. Pharmacol. Rev. 43: 109-142.
31. Mukherjee, D., Nissen, S.E., and Topol, E.J. 2001. J. Am. Med. Assoc. 286: 954-959.
32. Ohshiro, T., Namatame, I., Lee, E.W., Kawagishi, H., and Tomoda, H. 2006. Biol. Pharm. Bull. 29: 981-984.
33. Oliveira de Melo, J., da Conceição Torrado Truiti, M., Muscará, M.N., Bolonheis, S.M., Dantas, J.A., Caparroz-Assef, S.M., Cuman, R.K., and Bersani-Amado, C.A. 2006. Biol. Pharm. Bull. 29: 2241-2245.
34. Pang, L. and Hoult, J.R. 1997. Biochem. Pharmacol. 53: 773-782.
35. Park, H.H., Lee, S., Son, H.Y., Park, S.B., Kim, M.S., Choi, E.J., Singh, T.S., Ha, J.H., Lee, M.G., Kim, J.E., Hyun, M.C., Kwon, T.K., Kim, Y.H., and Kim, S.H. 2008. Arch. Pharm. Res. 31: 1303-1311.
36. Park, W.H., Park, S.Y., Kim, H.M., and Kim, C.H. 2004. Immunopharmacol. Immunotoxicol. 26: 53-73.
37. Ritchlin, C.T., Has-Smith, S.A., Li, P., Hicks, D.G., and Schwarz, E.M. 2003. J. Clin. Invest. 111: 821-831.
38. Romano, M., Faggioni, R., Sironi, M., Sacco, S., Echtenacher, B., Di Santo, E., Salmona, M., and Ghezzi, P. 1997. Mediat. Inflamm. 6: 32-38.
39. Tanaka, S., Kano, Y., Tabata, M., and Konoshima, M. 1971. Yakugaku Zasshi 91: 1098-1104.
40. Van Snick, J. 1990. Annu. Rev. Immunol. 8: 253-278.
41. Xie, Q.W., Whisnant, R., and Nathan, C. 1993. J. Exp. Med. 177: 1779-1784.
42. Wallace, J.L., Chapman, K., and Mcknight, W. 1999. Br. J. Pharmacol. 126: 1200-1204.
43. Yan, J.-J., Kim, D.-H., Moon, Y.-S., Jung, J.S., Ahn, E.-M., Baek, N.-I., and Song, D.-K. 2004. Prog.Neuropsychopharmacol. Biol. Psychiatry 28: 25-30.
44. Yui, Y., Hattori, R., Kosuga, K., Eizawa, H., Hiki, K., and Kawai, C. 1991. J. Biol. Chem. 266: 12544-12547.
45. Zanardo, R.C.O., Brancaleone, V., Distrutti, E., Fiorucci, S., Cirino, G., and Wallace, J.L. 2006. FASEB J. 20: 1411-1418.